SAN DIEGO -- December 18, 2000 -- Qualcomm Incorporated (Nasdaq: QCOM) and Anritsu Corporation today announced that they have entered into an amendment to Anritsu's existing Code Division Multiple Access (CDMA) test equipment license agreement with Qualcomm. Prior to the amendment, Anritsu's CDMA license covered only cdmaOne™ applications. With the amendment, Anritsu's CDMA agreement has now been expanded to grant Anritsu a royalty-bearing license under Qualcomm's essential CDMA patent portfolio to develop, manufacture and sell test equipment for third-generation (3G) CDMA (WCDMA, cdma2000, TD-SCDMA) and 1xEV (HDR) applications.
"Qualcomm is pleased to expand Anritsu's license to help expand their product offerings and fuel the continued growth of CDMA worldwide," said Steve Altman, president of Qualcomm Technology Alliances. "This agreement enables Anritsu to provide essential test equipment that will play a role in the growth of 3G CDMA systems."
"Anritsu is committed to providing high quality test products to service providers and manufacturers," said Scott Sullivan, assistant general manager of Anritsu's Applied Technology Division. "Extending the license for Qualcomm's CDMA technologies ensures that Anritsu will deliver on this commitment through its ability to offer test products that will advance the deployment of 3G CDMA networks."
Anritsu Corporation is a leading global manufacturer of information and communications, industrial automation, and test and measurement products and services recognized for technological innovation and quality. Anritsu employs more than 5,000 people in 18 countries around the world.
Qualcomm Incorporated (www.qualcomm.com) is a leader in developing and delivering innovative digital wireless communications products and services based on the Company's CDMA digital technology. The Company's business areas include integrated CDMA chipsets and system software; technology licensing; Eudora® email software for Windows® and Macintosh® computing platforms; digital cinema systems; and satellite-based systems including portions of the Globalstar™ system and wireless fleet management systems, OmniTRACS® and OmniExpress™. Qualcomm owns patents that are essential to all of the CDMA wireless telecommunications standards that have been adopted or proposed for adoption by standards-setting bodies worldwide. Qualcomm has licensed its essential CDMA patent portfolio to more than 90 telecommunications equipment manufacturers worldwide. Headquartered in San Diego, Calif., Qualcomm is included in theS&P500 Index and is a 2000 FORTUNE 500® company traded on The Nasdaq Stock Market® under the ticker symbol QCOM.
Except for the historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties, including the Company's ability to successfully design and have manufactured significant quantities of CDMA components on a timely and profitable basis, the extent and speed to which CDMA is deployed, change in economic conditions of the various markets the Company serves, as well as the other risks detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended September 24, 2000, and most recent Form 10-Q.
Qualcomm, OmniTRACS and Eudora are registered trademarks, and OmniExpress is a trademark of Qualcomm Incorporated. cdmaOne is a trademark of the CDMA Development Group (CDG). Globalstar is a trademark of Loral Qualcomm Satellite Services, Incorporated. Windows is a registered trademark of Microsoft Corp. Macintosh is a registered trademark of Apple Computer Inc. All other trademarks are the property of their respective owners.
December 18, 2000December 18, 2000